Kangyuxin Biotechnology Co., Ltd. was established in October 2013, specializing in the research and development, production, sales and related service technology development of pyrazine intermediates and process libraries. The core technology of pyrazine derivatives of Kangyuxin ranks the leading level in China, and the R&D varieties and market share of pyrazine series products rank the first in the subdivision field, and have been successfully approved as "Gansu Province Specialized and special small and medium-sized enterprises", "National high-tech enterprises" and "Gansu Province Enterprise Technology Center".
Kangyuxin has established long-term technical exchange relations with Lanzhou University, Northwest Normal University, Shanghai Organic Research Institute and other famous domestic universities and research institutes, with profound scientific research strength support, and hired a group of professors and industry experts as R & D guidance, to build a bridge between industry and intelligence. The company has a group of masters, doctors and long-term work in the industry of the front line of senior engineers composed of high-quality R & D experts and production management team, in recent years, has obtained a number of authorized invention patents, the development of more than 50 proprietary technology and nearly 100 kinds of products. In the past three years, a total of 30 million research and development funds have been invested, 60 sets of key production equipment and analysis and testing equipment have been purchased, and 2,000 square meters of standardized synthesis laboratories have been built, effectively guaranteeing the development of new products. Nearly 20 national and provincial scientific research projects have been implemented, such as "Focusing on integrated innovation in the field of pyrazine innovative drugs", "Fapiravir new process", and "Research and development of pyrazine methylamine pharmaceutical intermediates".
The CDMO workshop of Kang Yu Xin has completed the scale-up production of many key intermediates for new drugs, such as Fapiiravir, acatinib and entativir, and has become one of the main suppliers of key intermediates for many new pyrazines. The company has extensive cooperation with many international large companies, providing lasting impetus for the medium and long-term development of enterprises. Kangyuxin attaches great importance to product quality, and has established a perfect quality system, with environmental protection, efficient production equipment, advanced testing instruments, the production of pyrazine products in the world occupies a leading position.
Looking forward to the future, "do a good job of every pyrazine molecule". The company will focus on the development of pyrazine apis and intermediates, and build a pyrazine drug research and development and production service base to create a good situation of R&D, process development and production.
Kangyuxin will comply with the medical and chemical industry policy, increase technological innovation, accelerate transformation and upgrading, rely on the big health industry, do solid work, pioneering and innovative, improve the core competitiveness of the enterprise, and strive to build a green R & D and production enterprise with international competitiveness and popularity.
Scan code attention
